San Francisco, CANCT07405359Now EnrollingIRB Ready

Persistent Atrial Fibrillation Clinical Trial in San Francisco, CA

Access cutting-edge persistent atrial fibrillation treatment through this clinical trial at a research site in San Francisco. Study-provided care at no cost to qualified participants.

Sponsored by Edward Gerstenfeld, MD

Quick Self-Assessment

See if you qualify for this San Francisco location

Preparing your pre-screening questions…

Expert Care in San Francisco

Access persistent atrial fibrillation specialists at no cost

IRB Approved

This study follows strict safety protocols and ethical guidelines

No-Cost Care

All study-related persistent atrial fibrillation treatment provided free

Apply for This San Francisco Location

Check if you qualify for this persistent atrial fibrillation clinical trial in San Francisco, CA

Secure & Confidential

Your information is protected and will only be shared with the research team.

Why Participate?

  • No-Cost Study Care

  • Local to San Francisco

    Convenient for CA residents

  • Cutting-Edge Treatment

    Access to innovative therapies

  • Expert Medical Care

    Close monitoring by specialists

  • Possible Compensation*

    For time and travel

*Compensation varies by study. Confirm details with coordinator.

Simple Process

  1. 1Submit this form
  2. 2Phone screening
  3. 3Visit San Francisco site if eligible
  4. 4Begin participation

About This Persistent Atrial Fibrillation Study in San Francisco

Catheter based ablation of atrial fibrillation (AF) is an established treatment modality for rhythm control of AF, with pulmonary vein isolation (PVI) being the cornerstone of this technique. While pulmonary vein triggers are the predominant arrhythmia mechanism in paroxysmal AF, development of additional atrial substrate contributes to maintenance of AF in persistent AF. This is likely to account for the lower rates of freedom from recurrent AF following ablation in patients with persistent AF. Various adjunctive empiric ablation strategies, such as left atrial posterior wall isolation (PWI), superior vena cava isolation (SVCI), linear ablation, and ablation of complex fractionated atrial electrograms have been studied to address this limitation of PVI alone. While observational data supports the safety and feasibility of Posterior Wall Isolation (PWI) and Superior Vena Cava Isolation (SVCI) with PFA, the efficacy of these strategies with PFA has not been demonstrated in randomized controlled trials. Whether mapping prior to ablation (i.e. detecting scar) predicts if PW and SVC sites are effective in improving ablation outcome is unknown. This study will test the hypothesis of whether empiric addition of PW and SVC isolation with PFA to PVI improves outcome (freedom from atrial tachyarrhythmia at 1-year). The investigators therefore propose a randomized controlled trial to compare the efficacy of Pulmonary Vein Isolation (PVI) alone versus PVI + PWI + SVCI in patients with persistent AF. The investigators hypothesize that the addition of PWI and SVCI to PVI in patients with persistent AF will provide improved freedom from AFIB off anti-arrhythmic drugs, without significantly increasing rates of procedural complications. Secondary analysis includes subgroups with posterior wall scar, procedure times, freedom from AFIB on or off anti arrhythmic drugs, etc.

Sponsor: Edward Gerstenfeld, MD

Who Can Participate

Inclusion Criteria

Age ≥18 years at their pre-procedure visit
Persistent AF, defined as at least one continuous AF episode lasting at least seven days in duration, documented by a continuous monitor or 2 ECGs\>7 days apart or ≥3 cardioversions
Indicated and interested in ICM implant for monitoring post ablation
Written informed consent obtained from subject and ability for subject to comply with the requirements of the study

Exclusion Criteria

Any prior atrial endocardial or epicardial ablation procedure, other than cavotricuspid isthmus ablation or supraventricular tachycardia
Stroke or transient ischemic attack within the previous six months
Gastrointestinal bleeding within the previous three months
Implanted pacemaker or defibrillator
Longstanding persistent AF (\> 3 years)
LA volume \>80ml/m2
Atrial septal occlusion device
Current left atrial thrombus
Left atrial appendage occlusion or closure device \< 6 mos or with leak or prior DRT
Mitral or Tricuspid valve clip or mechanical replacement or clip
Hypertrophic cardiomyopathy
Contraindication to femoral vascular access
Congenital heart disease with residual anatomic abnormality
Contraindication to, or unwillingness to use, systemic anticoagulation
Left ventricular ejection fraction \<30%
Baseline creatinine \>2.0 mg/dL
Predicted life expectancy less than one year
Refusal to receive ICM implant or allergy to ICM

Not sure if you qualify? Submit your interest and a study coordinator will help determine your eligibility.

Frequently Asked Questions

Q:Is this study available in San Francisco?

Yes, this clinical trial (NCT07405359) has an active research site in San Francisco, CA that is currently enrolling participants.

Q:Is it safe to participate?

Clinical trials follow strict safety guidelines and ethical standards. This study has been reviewed and approved, and participants are closely monitored by medical professionals. You can withdraw at any time.

Q:Will I be compensated?

Many clinical trials offer compensation for your time and travel expenses. Specific compensation details will be discussed during the screening process. All study-related medical care is provided at no cost.

Q:Can I leave the trial if I change my mind?

Absolutely. Participation is completely voluntary. You have the right to withdraw from the study at any time, for any reason, without penalty.

Still have questions? Our study coordinators are here to help.

Persistent Atrial Fibrillation Treatment Options in San Francisco, CA

If you're searching for persistent atrial fibrillation treatment options in San Francisco, CA, this clinical trial (NCT07405359) may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.

Our San Francisco research site is actively enrolling participants for this clinical trial. You'll receive care from experienced persistent atrial fibrillation specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.

Looking for more options? Browse all persistent atrial fibrillation clinical trials near you to find additional studies recruiting in your area.

More Atrial Fibrillation Trials in San Francisco, CA

See all atrial fibrillation clinical trials recruiting in San Francisco — not just this study.

Browse Atrial Fibrillation Trials in San Francisco →

Ready to Join in San Francisco?

Take the first step toward participating in this groundbreaking clinical trial

Secure · Expert Care · San Francisco, CA